Gainers

• Modular Medical (NASDAQ:MODD) stock rose 15.8% to $0.29 during Friday's after-market session. The market value of their outstanding shares is at $34.1 million.
• Ernexa Therapeutics (NASDAQ:ERNA) stock moved upwards by 5.85% to $0.3. The company's market cap stands at $8.0 million.
• Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 4.12% to $6.82. The market value of their outstanding shares is at $9.5 million.
• Myomo (AMEX:MYO) stock increased by 2.47% to $0.79. The market value of their outstanding shares is at $30.1 million.
• AlphaTON Capital (NASDAQ:ATON) shares increased by 2.43% to $0.42. The market value of their outstanding shares is at $5.7 million.
• Catalyst Pharmaceuticals (NASDAQ:CPRX) stock moved upwards by 1.99% to $23.54. The market value of their outstanding shares is at $3.0 billion. As per the press release, Q4 earnings came out 2 days ago.

Losers

• Quince Therapeutics (NASDAQ:QNCX) stock declined by 4.7% to $0.12 during Friday's after-market session. The company's market cap stands at $7.7 million.
• Autonomix Medical (NASDAQ:AMIX) shares fell 4.29% to $0.42. The company's market cap stands at $4.6 million.
• Klotho Neurosciences (NASDAQ:KLTO) stock declined by 3.88% to $0.51. The market value of their outstanding shares is at $34.6 million.
• Akanda (NASDAQ:AKAN) shares declined by 3.85% to $1.0. The market value of their outstanding shares is at $1.9 million.
• BioAtla (NASDAQ:BCAB) stock fell 2.27% to $0.24. The company's market cap stands at $17.6 million.
• X4 Pharmaceuticals (NASDAQ:XFOR) stock decreased by 1.75% to $3.38. The company's market cap stands at $284.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.